PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Palforzia (peanut protein) - Peanut allergy in children and young people

PAD Profile : Palforzia (peanut protein) - Peanut allergy in children and young people

Keywords :
hyposensitising agents
Brand Names Include :
Palforzia

Traffic Light Status

Status 1 of 1.

Status :
Red
Important
Formulations :
  • Not Specified
Important Information :
Service not currently provided by Surrey Heartlands Trusts
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

No drugs returned.

Other Indications

Additional Documents

Committee Recommendations

Date
Committee Name
Narrative
04 May 2022
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

The Surrey Heartlands Integrated Care System Area Prescribing Committee recommends Palforzia for treating peanut allergy in children and young people in line with NICE TA 769.

Palforzia will be considered RED on the traffic light system. Prescribing will be by hospital specialists only, in line with NICE TA769.

Primary care prescribers should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient's medication

Associated BNF Codes

03. Respiratory System
03.04.02. Allergen immunotherapy
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More